Genomic amplifications identified by circulating tumor DNA analysis guide prognosis in metastatic castration-resistant prostate cancer

Overview of attention for article published in Frontiers in oncology, February 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 4 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 19,034 followers.

RT @FrontOncology: New research: Genomic amplifications identified by circulating tumor DNA analysis guide prognosis in metastatic castrati…

23 Feb 2024

Reply Repost Favourite

New research: Genomic amplifications identified by circulating tumor DNA analysis guide prognosis in metastatic castration-resistant prostate cancer: Purpose Analysis of circulating tumor DNA (ctDNA) in patients with metastatic prostate cancer… https://t.

22 Feb 2024

Reply Repost Favourite

In this paper, we show further evidence for the use of ctDNA analysis to determine prognosis throughout treatment of metastatic castration-resistant prostate cancer. @muschollings @FrontOncology #prostatecancer https://t.co/AoY2KzTQm1

22 Feb 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.